<<

1390 Federal Register / Vol. 79, No. 5 / Wednesday, January 8, 2014 / Notices

Drug Schedule Drug Schedule DEPARTMENT OF JUSTICE

Methcathinone (1237) ...... I (9143) ...... II Drug Enforcement Administration Mephedrone (1248) ...... I (9150) ...... II N-Ethylamphetamine (1475) ...... I Ecgonine (9180) ...... II Manufacturer of Controlled N,N-Dimethylamphetamine (1480) I (9190) ...... II Substances; Notice of Application; Fenethylline (1503) ...... I Meperidine (9230) ...... II Noramco, Inc. (GA) Gamma Hydroxybutyric Acid I (9250) ...... II (2010). JWH-018 (7118) ...... I , bulk (9273) II Pursuant to 21 CFR 1301.33(a), this is JWH-073 (7173) ...... I (9300) ...... II notice that on July 4, 2013, Noramco, JWH-200 (7200) ...... I (9330) ...... II Inc., 1440 Olympic Drive, Athens, Alpha-ethyltryptamine (7249) ...... I (9333) ...... II Georgia 30601, made application by (7260) ...... I Levo-alphacetylmethadol (9648) .. II renewal to the Drug Enforcement CP-47497 (7297) ...... I (9652) ...... II Administration (DEA) to be registered as CP-47497 C8 Homologue (7298) I Poppy Straw Concentrate (9670) II a bulk manufacturer of the following Lysergic acid diethylamide (7315) I (9737) ...... II basic classes of controlled substances: -T-7 (7348) ...... I (9740) ...... II Marihuana (7360) ...... I (9801) ...... II (7370) ..... I Drug Schedule (7381) ...... I 3,4,5- I The company plans to import small Gamma Hydroxybutyric Acid I (7390). (2010). quantities of the listed controlled (9145) ...... I 4-Bromo-2,5- I substances for the manufacture of dimethoxyamphetamine (7391). Morphine-N-oxide (9307) ...... I 4-Bromo-2,5- I analytical reference standards. -N-oxide (9053) ...... I dimethoxyphenethylamine In reference to drug codes 7360 and (1100) ...... II (7392). 7370, the company plans to import a (1724) ...... II 4-Methyl-2,5- I synthetic and a synthetic Codeine (9050) ...... II dimethoxyamphetamine (7395). . No other (9120) ...... II 2,5-Dimethoxyamphetamine I Oxycodone (9143) ...... II activities for these drug codes are (7396). Hydromorphone (9150) ...... II 3,4-Methylenedioxyamphetamine I authorized for this registration. (9193) ...... II (7400). Comments and requests for hearings Morphine (9300) ...... II 3,4-Methylenedioxy-N- I on applications to import narcotic raw Oripavine (9330) ...... II ethylamphetamine (7404). Thebaine (9333) ...... II 3,4- I material are not appropriate. 72 FR Methylenedioxymethamphetam- 3417(2007) tincture (9630) ...... II ine (7405). Oxymorphone (9652) ...... II DEA has considered the factors in 21 Noroxymorphone (9668) ...... II 4-Methoxyamphetamine (7411) ... I U.S.C. 823(a) and 952(a) and determined 5-Methoxy-N-N- I Alfentanil (9737) ...... II dimethyltryptamine (7431). that the registration of Cerilliant (9739) ...... II Alpha-methyltryptamine (7432) .... I Corporation to import the basic classes Sufentanil (9740) ...... II (7434) ...... I of controlled substances is consistent (9743) ...... II Dimethyltryptamine (7435) ...... I with the public interest and with United (9780) ...... II (7437) ...... I States obligations under international Fentanyl (9801) ...... II Psilocyn (7438) ...... I treaties, conventions, or protocols in 5-Methoxy-N,N- I diisopropyltryptamine (7439). effect on May 1, 1971. DEA has The company plans to manufacture N- (7493) ...... I investigated Cerilliant Corporation to the listed controlled substances in bulk MDPV (7535) ...... I ensure that the company’s registration is for distribution to its customers. Methylone (7540) ...... I consistent with the public interest. The (9055) ...... I Any other such applicant, and any investigation has included inspection person who is presently registered with (except HCl)(9056) ...... I and testing of the company’s physical (9200) ...... I DEA to manufacture such substance, Morphine-N-oxide (9307) ...... I security systems, verification of the may file comments or objections to the Normorphine (9313) ...... I company’s compliance with state and issuance of the proposed registration Pholcodine (9314) ...... I local laws, and a review of the pursuant to 21 CFR 1301.33(a). (9613) ...... I company’s background and history. (9622) ...... I Any such written comments or Therefore, pursuant to 21 U.S.C. 952(a) objections should be addressed, in Racemoramide (9645) ...... I and 958(a), and in accordance with 21 Trimeperidine (9646) ...... I quintuplicate, to the Drug Enforcement 1-Methyl-4-phenyl-4- I CFR 1301.34, the above named company Administrator, Office of Diversion propionoxypiperidine (9661). is granted registration as an importer of Control, Federal Register Representative (9750) ...... I the basic classes of controlled (ODW), 8701 Morrissette Drive, Amphetamine (1100) ...... II substances listed. Springfield, Virginia 22152; and must be (1105) ...... II filed no later than March 10, 2014. Methylphenidate (1724) ...... II Dated: December 23, 2013. Amobarbital (2125) ...... II Joseph T. Rannazzisi, Dated: December 23, 2013. Pentobarbital (2270) ...... II Deputy Assistant Administrator, Office of Joseph T. Rannazzisi, Secobarbital (2315) ...... II Diversion Control, Drug Enforcement Deputy Assistant Administrator, Office of (7471) ...... II Administration. Diversion Control, Drug Enforcement Phenylacetone (8501) ...... II Administration. (9041) ...... II [FR Doc. 2014–00057 Filed 1–7–14; 8:45 am] Codeine (9050) ...... II BILLING CODE 4410–09–P [FR Doc. 2014–00054 Filed 1–7–14; 8:45 am] Dihydrocodeine (9120) ...... II BILLING CODE 4410–09–P

VerDate Mar<15>2010 16:42 Jan 07, 2014 Jkt 232001 PO 00000 Frm 00029 Fmt 4703 Sfmt 9990 E:\FR\FM\08JAN1.SGM 08JAN1 mstockstill on DSK4VPTVN1PROD with NOTICES